| Literature DB >> 25034079 |
Melissa S Simper1, Joyce E Rundhaug1, Carol Mikulec1, Rebecca Bowen1, Jianjun Shen1, Yue Lu1, Kevin Lin1, Inok Surh1, Susan M Fischer2.
Abstract
To determine whether the EP4 receptor for prostaglandin E2 (PGE2) contributes to the tumor promoting activity of PGs in murine skin, EP4 over-expressing mice (BK5.EP4) were generated and subjected carcinogenesis protocols. An initiation/promotion protocol resulted in 25-fold more squamous cell carcinomas (SCCs) in the BK5.EP4 mice than wild type (WT) mice. An increase in SCCs also occurred following treatment with initiator alone or UV irradiation. The initiator dimethylbenz[a]anthracene caused cytotoxicity in BK5.EP4, but not WT mice, characterized by sloughing of the interfollicular epidermis, regeneration and subsequent SCC development. A comparison of transcriptomes between BK5.EP4 and WT mice treated with PGE2 showed a significant upregulation of a number of genes known to be associated with tumor development, supporting a pro-tumorigenic role for the EP4 receptor.Entities:
Keywords: EP4 receptor; Murine skin; Prostaglandin E(2); Skin tumors; Tumor promotion
Mesh:
Substances:
Year: 2014 PMID: 25034079 PMCID: PMC4253556 DOI: 10.1016/j.molonc.2014.06.013
Source DB: PubMed Journal: Mol Oncol ISSN: 1574-7891 Impact factor: 6.603